Recombinant Humanized Antibody (KD-247) is capable of binding to HIV-1 gp120, expressed in mammalian cells. This antibody can neutralize a broad spectrum of CCR5- and CXCR4-tropic viruses and HIV-1 quasi-species.
Figure 1 The gp120 mutation profile of HIV-1BaL evasion variants from KD-247 in vitro.
The ratio of the PNGS insertion in the V2 region and mutations in the C2 and V3 regions in gp120 of HIV-1BaL variants were plotted for each passage. The y-axis indicates the percentage of PNGS insertions or mutations in the tested clones and the x-axis shows the concentration of KD-247 (μg/ml).
Hatada, M., Yoshimura, K., Harada, S., Kawanami, Y., Shibata, J., & Matsushita, S. (2010). Human immunodeficiency virus type 1 evasion of a neutralizing anti-V3 antibody involves acquisition of a potential glycosylation site in V2. Journal of General Virology, 91(5), 1335-1345.
Figure 2 Sensitivities of HIV-1 strains pseudo-typed with recombinant HIV-1BaLenv genes to KD-247 inhibitor.
KD-247 was pre-incubated with 300 TCID50 of each HIV-1BaL pseudotype virus for 30 min, then added to TZM-bl target cells. Inhibitory effects were determined by measuring β-galactosidase activity on day 2 of culture.
Hatada, M., Yoshimura, K., Harada, S., Kawanami, Y., Shibata, J., & Matsushita, S. (2010). Human immunodeficiency virus type 1 evasion of a neutralizing anti-V3 antibody involves acquisition of a potential glycosylation site in V2. Journal of General Virology, 91(5), 1335-1345.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
NABG-082 | Recombinant Anti-HIV-1 gp120 VHH Single Domain Antibody | ELISA, IHC, FC, FuncS | Llama VHH |
MRO-028LC-VHH | Anti-HIV-1 gp120 Recombinant Antibody (MRO-028LC-VHH) | ELISA | Single domain antibody |
MRO-029LC-VHH | Anti-HIV-1 gp120 Recombinant Antibody (MRO-029LC-VHH) | ELISA | Single domain antibody |
MRO-030LC-VHH | Anti-HIV-1 gp120 Recombinant Antibody (MRO-030LC-VHH) | ELISA | Single domain antibody |
MRO-031LC-VHH | Anti-HIV-1 gp120 Recombinant Antibody (MRO-031LC-VHH) | ELISA | Single domain antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBL-380 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone VRC06); scFv Fragment | Neut, FuncS | Human scFv |
MRO-2788CQ-S(P) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 570-D); scFv Fragment | ELISA | Human scFv |
MRO-2792CQ-S(P) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone gVRC-H10dC38/VRC01L); scFv Fragment | ELISA, Neut | Human scFv |
MRO-2793CQ-S(P) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone gVRC-H1dC38/VRC01L); scFv Fragment | ELISA, Neut | Human scFv |
MRO-3149CQ-S(P) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone D02-6); scFv Fragment | ELISA, FC | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBL-135 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone PGT135); Fab Fragment | ELISA, Neut | Human Fab |
PFBL-142 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 412d); Fab Fragment | WB, ELISA, FuncS | Human Fab |
PFBL-155 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone VRC03); Fab Fragment | WB, ELISA, Neut, FuncS | Human Fab |
PSBZ-209 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 19.3H-L3); scFv Fragment | Neut | Human scFv |
PSBZ-210 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 19.3H-L1); scFv Fragment | Neut | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-520 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 44-VRC13.01) | Neut | Human IgG |
PABL-521 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 45-46M2) | ELISA, Neut | Human IgG |
PABL-522 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 45-VRC01.H5.F-185917) | WB, FuncS | Human IgG |
PABL-523 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 8ANC131) | WB, FuncS | Human IgG |
PABL-524 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 8ANC134) | WB, IHC, IF, FuncS | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-041LC | Anti-HIV-1 gp120 Recombinant Antibody (D59/A2) | ELISA | Mouse antibody |
MRO-042LC | Anti-HIV-1 gp120 Recombinant Antibody (F58/H3) | WB, ELISA | Mouse antibody |
MRO-043LC | Anti-HIV-1 gp120 Recombinant Antibody (P1/D12) | ELISA | Mouse antibody |
MRO-044LC | Anti-HIV-1 gp120 Recombinant Antibody (P4/D10) | ELISA | Mouse antibody |
MRO-045LC | Anti-HIV-1 gp120 Recombinant Antibody (A47/B1) | ELISA | Mouse antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-135LC | Anti-HIV-1 gp120 Recombinant Antibody (CAG1-51-4) | ELISA, WB, Neut | Chimeric antibody (mouse/human) |
MRO-135LC-S(P) | Anti-HIV-1 gp120 Recombinant Antibody scFv Fragment (CAG1-51-4) | ELISA, WB | Chimeric antibody (mouse/human) |
MRO-135LC-F(E) | Anti-HIV-1 gp120 Recombinant Antibody Fab Fragment (CAG1-51-4) | ELISA, WB | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-155LC | Anti-HIV-1 gp120 Recombinant Antibody (GP44) | ELISA | Human antibody |
MRO-156LC | Anti-HIV-1 gp120 Recombinant Antibody (GP68) | ELISA, Inhib | Human antibody |
MRO-157LC | Anti-HIV-1 gp120 Recombinant Antibody (MN215) | ELISA | Human antibody |
MRO-161LC | Human Anti-HIV-1 gp120 Recombinant Antibody (MRO-161LC) | ELISA | Human IgG1, κ |
MRO-162LC | Human Anti-HIV-1 gp120 Recombinant Antibody (MRO-162LC) | ELISA, FC, Neut, SPR | Human IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-4220 | Rabbit Anti-HIV-1 gp120 Recombinant Antibody (clone SI299DS) | WB, ELISA | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
PABX-101-S(P) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone PG9); scFv Fragment | WB, ELISA, FuncS | Human scFv |
There are currently no Customer reviews or questions for PABL-546. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.